Airsonett TLA har genomgått omfattande kliniska studier. Klinisk data har utvärderats och rekommenderas av ett flertal medicinska organisationer. Kontakta oss gärna om du vill veta mer eller boka ett möte för en utförlig presentation.
reviews the guidelines and still recommends TLA as an add-on treatment for Asthma
Renewed recommendation
Also recommended for Atopic Dermatitis: “Treatment with Airsonett can be particularly valuable in the combination of severe asthma and severe eczema, as the treatment affects both conditions favourably.”
recommends TLA for ”patients with verified perennial airway allergy and uncontrolled asthma despite drug treatment step 4”
Add-on treatment asthma (MPO)
considers treatment with TLA to be cost-effective given the data available, provided that the patient corresponds to the indication.
”Treatment with Airsonett can be particularly valuable in the combination of severe asthma and severe eczema, as the treatment affects both conditions favourably.”